Iovance Biotherapeutics IOVA
NASDAQ IOVA
$14.44 +3.45 (+31.35%)
As of: Sep 29, 2026 · 3:59 PM EDT

Iovance Biotherapeutics (IOVA) Finished Goods (2023 - 2025)

Updated

Iovance Biotherapeutics (IOVA) posted Finished Goods of $15.55 million for Q1 2025, up 153.3% from $6.14 million a year earlier and up 3.6% from the prior quarter.

Analysis

Iovance Biotherapeutics (IOVA) Finished Goods (2023 - 2025) Analysis & Trends

At the end of FY2024, Iovance Biotherapeutics' Finished Goods came in at $15.01 million, up 224.7% from FY2023.

  • In prior years, Iovance Biotherapeutics' Finished Goods was $4.62 million in FY2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn
10 Iovance Biotherapeutics 4.98 Bn 3.77 Bn 55.72 Mn
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2025 15.55 Mn
Dec 31, 2024 15.01 Mn
Mar 31, 2024 6.14 Mn
Dec 31, 2023 4.62 Mn
Sep 30, 2023 4.89 Mn
Jun 30, 2023 1.13 Mn
API Access

Iovance Biotherapeutics Finished Goods API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=finished-goods&ticker=IOVA&period=max&api_key=YOUR_API_KEY